Self-association and cyclodextrin solubilization of drugs

Journal of Pharmaceutical Sciences

Volumn 91, Issue 11, 2002, Pages 2307-2316

  Loftsson, Thorsteinn ^a   Magnúsdóttir, Auour ^b   Másson, Már ^a   Sigurjónsdóttir, Jóhanna F ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b DECODE GENETICS   (Iceland)

Author keywords

Aggregates; Complexation; Cyclodextrin; Self association; Solubilization

Indexed keywords

ALPRAZOLAM; CHOLESTEROL; CYCLODEXTRIN; DIETHYLSTILBESTROL; DIFLUNISAL; DRUG; ESTRADIOL; IBUPROFEN;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG SOLUBILITY; DRUG STRUCTURE; MOLECULAR MODEL; STOICHIOMETRY;

EID: 0036827954     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10226     Document Type: Article

References (29)

1. Loftsson T, Brewster ME. 1996. Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J Pharm Sci 85(10):1017-1025.
2. Connors KA. 1997. The stability of cyclodextrin complexes in solution. Chem Rev 97:1325-1357.
3. Stella VJ, Rajewski RA. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 14(5):556-567.
4. Uekama K, Hirayama F, Irie T. 1998. Cyclodextrin drug carrier systems. Chem Rev 98:2045-2076.
5. Higuchi T, Connors KA. 1965. Phase-solubility techniques. Adv Anal Chem Instrum 4:117-212.
6. Repta AJ. 1985. Alteration of apparent solubility through complexation. In: Yalkowski SH, editor. Techniques of Solubilization of Drugs. Marcel Dekker. New York: pp 135-157.
7. Hirayama F, Uekama K. 1987. Methods of investigating and preparing inclusion compounds. In: Duchêne D, editor. Cyclodextrins and Their Industrial Uses. Paris: Editions de Santé. pp 131-172.
8. Bodor N, Buchwald P, Huang M-J. 1999. The role of computational techniques in retrometabolic drug design strategies. Theor Computat Chem 8:569-618.
9. Szente L, Szejtli J, Kis GL. 1998. Spontaneous opalescence of aqueous γ-cyclodextrin solutions: Complex formation or self-aggregation. J Pharm Sci 87:778-781.
10. Tomasik P, Schilling CH. 1998. Complexes of starch with organic guests. In: Horton D, editor. Advances in Carbohydrate Chemistry and Biochemistry. San Diego: Academic Press. pp 345-426.
11. Angelova A, Ringard-Lefebvre C, Baszkin A. 1999. Drug-cyclodextrin association constants determined by surface tension and surface pressure measurements. II. Sequestration of water insoluble drugs from air-water interface: Retinol-βcyclodextrin system. J Colloid Interface Sci 212:280-285.
12. Bettinetti G, Sorrenti M, Negri A, Setti M, Mura P, Melani F. 1999. Interaction of naproxen with alpha-cyclodextrin and its noncyclic analog maltohexaose. Pharm Res 16:689-694.
13. Ridell A, Evertsson H, Nilsson S, Sundelöf L-O. 1999. Amphiphilic association of ibuprofen and two nonionic cellulose derivatives in aqueous solution. J Pharm Sci 88:1175-1181.
14. Schreier S, Malheiros SVP, de Paula E. 2000. Surface active drugs: Self-association and interaction with membranes and surfactants: Physicochemical and biological aspects. Biochim Biophys Acta 1508:210-234.
15. Liptaj T, Pronayova N, Karlova K. 1995. NMR-study of the inclusion complex of surfactant N,N′-bis [4-(4-tert-butylphenoxy)butyldimethyl]-1,6-hexanediammonium dibromide with beta-cyclodextrin. Pharmazie 50:744-747.
16. Mele A, Mendichi R, Selva A. 1998. Non-covalent associations of cyclomaltooligosaccharides (cyclodextrins) with trans-β-carotene in water: Evidence for the formation of large aggregates by light scattering and NMR spectroscopy. Carbohydr Res 310:261-267.
17. Loftsson T, Másson M, Sigurdsson HH. 2002. Cyclodextrins and drug permeability through semipermeable cellophane membranes. Int J Pharm 232:35-43.
18. Loftsson T, Másson M, Sigurjónsdóttir JF. 1999. Methods to enhance the complexation efficiency of cyclodextrins. STP Pharma Sci 9:237-242.
19. Yalkowsky SH. 1999. Solubility and Solubilization in Aqueous Media. Washington DC: American Chemical Society.
20. Thompson DO. 1997. Cyclodextrins-enabling excipients: Their present and future use in pharmaceuticals. Crit Rev Ther Drug Carrier Syst 14(1):1-104.
21. Zia V, Rajewski RA, Stella VJ. 2001. Effect of cyclodextrin charge on complexation of neutral and charged substrates: Comparison of (SBE)7M-β-CD to HP-β-CD. Pharm Res 18:667-673.
22. Fini A, Fazio G, Feroci G. 1995. Solubility and solubilization properties of non-steroidal antiinflammatory drugs. Int J Pharm 126:95-120.
23. Moffat AC, editor. 1986. Clarke's Isolation and Identification of Drugs. London: Pharmaceutical Press.
24. Zornoza A, Sánchez M, Vélaz I, Fernandez L. 1999. Diflunisal and its complexation with cyclodextrins: A fluorometric study. Biomed Chromatogr 13:111-112.
25. Oh I, Lee M-Y, Lee Y-B, Shin SC, Park I. 1998. Spectroscopic characterization of ibuprofen/2-hydroxypropyl-β-cyclodextrin inclusion complex. Int J Pharm 175:215-223.
26. Sideris EE, Koupparis MA, Macheras PE. 1994. Effect of cyclodextrins on protein binding of drugs: The diflunisal hydroxypropyl-β-cyclodextrin model case. Pharm Res 11:90-95.
27. Ugwu SO, Alcala MJ, Bhardwaj R, Blanchard J. 1999. Complexation of diflunisal with hydroxypropyl-β-cyclodextrin. J Pharm Biomed Anal 19:391-397.
28. Sideris EE, Valsami GN, Koupparis MA, Macheras PE. 1999. Studies on the interaction of diflunisal ion with cyclodextrin use in ion-selective electrode potentiometry. Eur J Pharm Sci 7:271-278.
29. Irwin WJ, Chauhan N, Smith EL, Grattan TJ. 1995. The calculation of free drug concentration in cyclodextrin-drug complexes in the presence of competitors. Pharm Sci 1:423-427.